🧪
hypothesis

Complement Cascade as Final Common Effector

Hypothesis

Complement Cascade as Final Common Effector

Diverse myelopathy triggers activate the complement system through different pathways but converge on C5a/C5aR1 signaling in spinal cord tissue, creating uniform inflammatory milieu with standardized tissue damage patterns.
🧬 C5AR1🩺 neuroinflammation🎯 Composite 46%💱 $0.52▲5.2%active
EvidencePending (0%)📖 5 cit🗣 1 debates 5 support 1 oppose
✓ All Quality Gates Passed
Mechanistic 0.50 (15%) Evidence 0.50 (15%) Novelty 0.50 (12%) Feasibility 0.50 (12%) Impact 0.00 (12%) Druggability 0.50 (10%) Safety 0.50 (8%) Competition 0.50 (6%) Data Avail. 0.50 (5%) Reproducible 0.50 (5%) KG Connect 0.50 (8%) 0.455 composite
☰ Compare⚔️ Duel⚛️ Collide
📄 Export LaTeX
arXiv PreprintNeurIPSNature MethodsPLOS ONE
📖 Export BibTeXinteract with this hypothesis
Composite46%

🧪 Overview

Diverse myelopathy triggers activate the complement system through different pathways but converge on C5a/C5aR1 signaling in spinal cord tissue, creating uniform inflammatory milieu with standardized tissue damage patterns.

🧬 Mechanism

🧬 Curated Mechanism Pathway

Curated pathway from expert analysis

flowchart TD
    A["Spinal Cord Myelopathy Trigger<br/>ALS Trauma Autoimmune Ischemia"]
    B["Complement Activation<br/>Classical Lectin Alternative Pathway"]
    C["C3 Convertase Formation<br/>C3b Opsonization of Cord Tissue"]
    D["C5 Cleavage<br/>C5a Anaphylatoxin Released"]
    E["C5aR1 C5AR1 Signaling<br/>Spinal Microglia Myeloid Cells"]
    F["Uniform Inflammatory Milieu<br/>Common Downstream Effector Activated"]
    G["Standardized Neuroinflammation Pattern<br/>Convergent Spinal Cord Pathology"]
    H["C5aR1 Antagonist Treatment<br/>Avacopan PMX53"]
    I["Unified Therapeutic Strategy<br/>Across Diverse Myelopathy Triggers"]
    A --> B
    B --> C
    C --> D
    D --> E
    E --> F
    F --> G
    H -.->|"blocks convergent effector"| E
    H --> I
    style E fill:#7b1fa2,stroke:#ce93d8,color:#ce93d8
    style I fill:#1b5e20,stroke:#a5d6a7,color:#a5d6a7

⚖️ Evidence

⚖️ Evidence Matrix5 supports0 contradicts
Supports
C5aR1(+) microglia exacerbate neuroinflammation and cerebral edema in acute brain injury.
Neuron2026PMID:41260217medium
Supports
C5a-C5aR1 induces endoplasmic reticulum stress to accelerate vascular calcification via PERK-eIF2α-ATF4-CREB3L1 pathway.
Cardiovasc Res2023PMID:37603848medium
Supports
C5a-C5aR1 axis controls mitochondrial fission to promote podocyte injury in lupus nephritis.
Mol Ther2024PMID:38449312medium
Supports
C5a-licensed phagocytes drive sterilizing immunity during systemic fungal infection.
Cell2023PMID:37220746medium
Supports
Mitochondrial C5aR1 activity in macrophages controls IL-1β production underlying sterile inflammation.
Sci Immunol2021PMID:34932384medium
📖 Linked Papers

No linked papers recorded for this hypothesis yet.

🏥 Translation

🧬 3D Protein Structure — C5AR1

No curated PDB or AlphaFold mapping for C5AR1 yet. Search RCSB →

💉 Clinical Trials

No clinical trials data linked to this hypothesis yet.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for C5AR1 →

No DepMap CRISPR Chronos data found for C5AR1.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Stable
7d Momentum
▲ 0.0%
Volatility
High
0.0511
Events (7d)
0
Price History
▲5.2%

💾 Resource Usage

LLM Tokens
12,040
$0.0722
Total Cost
$0.0722
View on SciDEX ↗